67
Background:
Across the US, hospitalists increasingly manage solid tumor inpatients, yet the role of primary oncologists in this model is often undefined. At MD Anderson Cancer Center, consult rates by oncology services vary by more than two-fold across the four hospitalist-managed solid tumor departments. Pr...
K. Adelson, L. Pantoja, L. Jackson et al.· JCO Oncology Practice· 0 citations
596
Background:
Inpatient chemotherapy for gastrointestinal (GI) malignancies is used selectively for patients with urgent clinical needs or barriers to outpatient treatment, but indications, outcomes, and predictors of early mortality remain poorly defined. We characterized the clinical drivers and short-term...
A. Barabrah, M. Overman, Lian-Chun Xiao et al.· JCO Oncology Practice· 0 citations
Importance
Relapse risk and benefit of adjuvant chemotherapy after resection of appendiceal adenocarcinoma (AA) are uncertain.
Objective
To identify clinicopathologic and genomic factors associated with relapse and assess efficacy of adjuvant chemotherapy in localized AA.
Design, Setting, and Participants
This retr...
Sacha El Khoury, M. Fanaeian, M. Yousef et al.· JAMA Surgery· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
